Dr. Reddy’s Laboratories (DRREDDY)
NSE
- Open
- N/A
- High
- N/A
- Low
- N/A
- Volume
- N/A
- Market cap
- ₹227.24B
Dr. Reddy’s Laboratories (DRREDDY) last traded at ₹1,368.90 on NSE as of 6 Nov 2026, 13:12 GMT+0530.
Dr. Reddy’s Laboratories forecasts and price
Scroll here to load data.
Key statistics
Dr. Reddy’s Laboratories stock research: financials and ownership
Dr. Reddy’s Laboratories revenue, operating income and net income
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 1.00M |
| Shares Outstanding | 166.00M |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Dr. Reddy’s Laboratories revenue by segment
Scroll here to load data.
Dr. Reddy’s Laboratories revenue by region
Scroll here to load data.
Dr. Reddy’s Laboratories stock margins
Scroll here to load data.
Dr. Reddy’s Laboratories historical valuation
Scroll here to load data.
Dr. Reddy’s Laboratories annual returns
Scroll here to load data.
Dr. Reddy’s Laboratories financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
Related Articles & Updates
TechGraph News · 2026-10-18The Connected Exchange: NCDEX CTO Balkrishna Shankwalker on the Future of the Commodity Market
TechGraph News · 2026-10-15NumanCap Review 2026 | Markets, Margin and Mobile
TechGraph News · 2026-10-01What Does India’s First Tokenised Bond Pilot Mean for the Debt Market?
TechGraph News · 2026-09-15Javier Olivan Plans $1.04 Million Meta Share Sale
TechGraph News · 2026-09-13NVIDIA Awards 172,507 Shares to EVP Nicholas Parker
TechGraph News · 2026-09-13Meta CPO Chris Cox Sells Shares Worth $13 Mn
Dr. Reddy’s Laboratories fair value
Discounted cash flow fair value compared with the market price.
Scroll here to load data.
Dr. Reddy’s Laboratories company rating
Composite rating and the factor scores behind it.
Scroll here to load data.
Dr. Reddy’s Laboratories financial ratios
Trailing twelve month ratios.
Scroll here to load data.
Dr. Reddy’s Laboratories financial scores
Altman Z-score, Piotroski score and related health scores.
Scroll here to load data.
Dr. Reddy’s Laboratories one-year risk
One-year return, volatility, Sharpe ratio and max drawdown.
Scroll here to load data.
Dr. Reddy’s Laboratories peers
Related companies.
Scroll here to load data.
Dr. Reddy’s Laboratories earnings calls
Transcripts listed for this ticker.
Scroll here to load data.
People also watch
Trending global stocks
Related in Pharmaceuticals
About Dr. Reddy’s Laboratories
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting…
Founded byKallam Anji Reddy
Company profile
Dr. Reddy’s Laboratories executives and management
Dr. Reddy’s Laboratories — frequently asked questions
What is the Dr. Reddy’s Laboratories share price today?
Dr. Reddy’s Laboratories (DRREDDY) last traded at ₹1,368.90 on NSE as of 6 Nov 2026, 13:12 GMT+0530.
Where is Dr. Reddy’s Laboratories listed?
Dr. Reddy’s Laboratories trades as DRREDDY on NSE.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.